N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide

Preferred Label : N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide;

MeSH note : also inhibits HER2; structure in first source;

CISMeF synonym : TAK 285;

MeSH hyponym : TAK285; TAK-285;

Is substance : O;

UNII : 70CCB438L6;

Détails

Origin ID

C570404;

UMLS CUI

C3490488;

MeSH indexing information
- ErbB Receptors [MeSH Descriptor]
MeSH term(s) associated for indexing
- Bridged Bicyclo Compounds, Heterocyclic [MeSH Descriptor]
- hydroxybutyrates [MeSH Descriptor]
Record concept(s)
- N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo(3,2-d)pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide [MeSH concept]
- TAK 285 [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients